Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/36594
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMARTENS, Pieter-
dc.contributor.authorTang, W H Wilson-
dc.contributor.authorMULLENS, Wilfried-
dc.date.accessioned2022-02-03T09:18:17Z-
dc.date.available2022-02-03T09:18:17Z-
dc.date.issued2021-
dc.date.submitted2021-12-19T21:44:53Z-
dc.date.submitted2021-12-19T21:44:53Z-
dc.identifier.citationEuropean heart journal, 42 (43) , p. 4478 -+-
dc.identifier.urihttp://hdl.handle.net/1942/36594-
dc.description.abstractGraphical Abstract Summary findings (A) Pharmacological effect of loop diuretics in healthy individuals showing CPDSR and the breaking phenomenon. (B) Potential therapies targeting sodium avidity in AHF and CHF. (C) Theoretical effect of therapies used in AHF and CHF on renal sodium excretion throughout the day.-
dc.description.sponsorshipP.M. is supported by 1 year support from the Belgian American Educational Foundation (BAEF) and 1 year support from the Frans Van de Werf Fund. W.H.W.T is partially supported by grants from the National Institutes of Health (R01HL126827 and R01HL146754).-
dc.language.isoen-
dc.publisherOXFORD UNIV PRESS-
dc.rightsThe Author(s) 2021. For permissions, please email: journals.permissions@oup.com-
dc.subject.otherHumans-
dc.subject.otherKidney-
dc.subject.otherHeart Failure-
dc.subject.otherSodium-
dc.titleRenal sodium avidity, the prevailing renal target in heart failure-
dc.typeJournal Contribution-
dc.identifier.epage+-
dc.identifier.issue43-
dc.identifier.spage4478-
dc.identifier.volume42-
local.format.pages4-
local.bibliographicCitation.jcatA2-
dc.description.notesMartens, P (corresponding author), Ziekenhuis Oost Limburg, Dept Cardiol, Schiepse Bos 6, B-3600 Genk, Belgium.-
dc.description.notesPieter_martens@icloud.com-
local.publisher.placeGREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND-
local.type.refereedRefereed-
local.type.specifiedEditorial Material-
local.classdsPublValOverrule/author_version_not_expected-
dc.identifier.doi10.1093/eurheartj/ehab650-
dc.identifier.pmid34529790-
dc.identifier.isi000728161800013-
dc.contributor.orcidMartens, Pieter/0000-0002-6036-2113-
local.provider.typewosris-
local.uhasselt.uhpubyes-
local.description.affiliation[Martens, Pieter; Mullens, Wilfried] Ziekenhuis Oost Limburg, Dept Cardiol, Schiepse Bos 6, B-3600 Genk, Belgium.-
local.description.affiliation[Martens, Pieter; Tang, W. H. Wilson] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44106 USA.-
local.description.affiliation[Mullens, Wilfried] Hasselt Univ, Fac Med & Life Sci, Biomed Res Inst, Diepenbeek, Belgium.-
local.uhasselt.internationalno-
item.fulltextWith Fulltext-
item.contributorMARTENS, Pieter-
item.contributorTang, W H Wilson-
item.contributorMULLENS, Wilfried-
item.fullcitationMARTENS, Pieter; Tang, W H Wilson & MULLENS, Wilfried (2021) Renal sodium avidity, the prevailing renal target in heart failure. In: European heart journal, 42 (43) , p. 4478 -+.-
item.accessRightsRestricted Access-
crisitem.journal.issn0195-668X-
crisitem.journal.eissn1522-9645-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
OP-EHEA210655_online 4478..4481.pdf
  Restricted Access		Published version536.11 kBAdobe PDFView/Open    Request a copy
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.